When the second outweighs the first, the disclaimer fails
Supports maintenance of glutathione levels already in a healthy range
The key was setting clear rules: when I hit 215, I restart immediately
Store at room temperature away from direct sunlight and heat sources

For patients with type 2 diabetes and Hashimoto's, options include: Semaglutide (Ozempic) : Once-weekly injection with robust efficacy for glycemic control, weight loss, and cardiovascular risk reduction Semaglutide (Rybelsus) : Oral daily tablet requiring careful timing with levothyroxine Dulaglutide (Trulicity) : Once-weekly injection with established cardiovascular benefits Liraglutide (Victoza) : Daily injection with cardiovascular risk reduction and extensive long-term safety data Tirzepatide (Mounjaro) : Once-weekly injection combining GLP-1 and GIP receptor agonism, showing superior efficacy in clinical trials For patients with obesity and Hashimoto's, FDA-approved options include: Semaglutide (Wegovy) : Once-weekly injection at higher doses than Ozempic Liraglutide (Saxenda) : Daily injection Tirzepatide (Zepbound) : Once-weekly injection with significant weight loss efficacy The presence of Hashimoto's thyroiditis does not inherently favor one GLP-1 medication over another

Trigonelline The amount of trigonelline synthesized in the pericarp is significantly higher than that in the seeds, but part of the pericarpproduced trigonelline can be transferred to the seeds, resulting in a higher level of trigonelline in seeds than in the pericarp